Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?

Eijiro Shimada,Makoto Endo,Yoshihiro Matsumoto,Kenji Tsuchihashi,Mamoru Ito,Hitoshi Kusaba,Akira Nabeshima, Tomoya Nawata,Akira Maekawa,Tomoya Matsunobu,Nokitaka Setsu,Toshifumi Fujiwara,Keiichiro Iida,Makoto Nakagawa,Takeshi Hirose,Masaya Kanahori,Ryunosuke Oyama,Taichi Isobe,Hiroshi Ariyama,Kenichi Kohashi,Hidetaka Yamamoto,Yoshinao Oda,Yukihide Iwamoto,Koichi Akashi,Eishi Baba,Yasuharu Nakashima

JOURNAL OF CLINICAL MEDICINE（2021）

Cited 4|Views28
No score
Key words
soft tissue sarcoma,chemotherapy,pazopanib,trabectedin,eribulin,prognosis,biomarker,peripheral immune-related marker,neutrophil to lymphocyte ratio,platelet to lymphocyte ratio
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined